Phone (Direct)
+27 11 ❅❅❅ ❅❅❅❅
Phone (Direct)
Phone (Mobile)
+27 60 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
+41 613241111
Phone (HQ)
❅❅❅❅❅@novartis.com
Office Address (HQ)
Forum 1 Novartis Campus, Basel, Basel-City, 4056, Switzerland
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Darren Katzman
Novartis
Get Free Access to Darren’s Contact InfoAccording to Datanyze information, these are Darren Katzman's contact details. Reveal the hidden information below for FREE!
Phone (Direct)
+27 11 ❅❅❅ ❅❅❅❅
Phone (Direct)
Phone (Mobile)
+27 60 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
+41 613241111
Phone (HQ)
❅❅❅❅❅@novartis.com
Office Address (HQ)
Forum 1 Novartis Campus, Basel, Basel-City, 4056, Switzerland
Office Address (HQ)
Darren Katzman works as a Chief Scientific Officer and Medical Director at Novartis, which is a Manufacturing company with an estimated 76.1 K employees; and founded in 1996. They are part of the Research & Development team within the Engineering & Technical Department and their management level is C-Level. Darren is currently based in Johannesburg, South Africa. They used to work at N/A and GSK and have used the following emails: @novartis.com, @bayer.com.
Flattery will get you everywhere, offer Darren a compliment to ❄️
Darren Katzman's career began less then a year ago. Prior to joining Novartis, Darren worked at 8 companies.
ICAN Group
Managing Director
N/A
Locum Work
Vaccines R&D Mea Head
Crd Vaccines Africa & Middle Regional Head (East)
Medical Director
Medical Director
Clinical Operations Head
Schering-Plough Research Institute
Cra
Novartis
Forum 1 Novartis Campus, Basel, Basel-City, 4056, Switzerland
76.1 K
$47.7 B
Manufacturing, Pharmaceuticals
Get Full Profile Access
Ice Breakers
Imagine you could know all about Novartis - Darren Katzman’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Darren’s company in the news
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
September 5, 2024
Novartis boosts radiopharma production with expansion, new factory - Manufacturing Dive
September 4, 2024
Novartis begins construction of two new radioligand therapy facilities in the US, expanding its world-class RLT manufacturing and supply network
September 4, 2024
See more
Insights to Break the Ice
In your first interaction
Darren is located in South Africa
Work Colleague
See Darren Katzman's coworkers out of Novartis's 76.1 K employees